These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12536203)
1. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis. Levicar N; Dewey RA; Daley E; Bates TE; Davies D; Kos J; Pilkington GJ; Lah TT Cancer Gene Ther; 2003 Feb; 10(2):141-51. PubMed ID: 12536203 [TBL] [Abstract][Full Text] [Related]
2. Cathepsin L affects apoptosis of glioblastoma cells: a potential implication in the design of cancer therapeutics. Zajc I; Hreljac I; Lah T Anticancer Res; 2006; 26(5A):3357-64. PubMed ID: 17094453 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line. Krueger S; Haeckel C; Buehling F; Roessner A Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250 [TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas. Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of cathepsin B expression impairs the invasive and tumorigenic potential of human glioblastoma cells. Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Lakka SS; Kin Y; Fuller GN; Yung AW; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Rao JS Oncogene; 2001 Jun; 20(28):3665-73. PubMed ID: 11439329 [TBL] [Abstract][Full Text] [Related]
6. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835 [TBL] [Abstract][Full Text] [Related]
7. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype. Krueger S; Kellner U; Buehling F; Roessner A Cancer Gene Ther; 2001 Jul; 8(7):522-8. PubMed ID: 11498774 [TBL] [Abstract][Full Text] [Related]
8. Expression of antisense bcl-2 cDNA abolishes tumorigenicity and enhances chemosensitivity of human malignant glioma cells. Zhu CJ; Li YB; Wong MC J Neurosci Res; 2003 Oct; 74(1):60-6. PubMed ID: 13130506 [TBL] [Abstract][Full Text] [Related]
9. Effects of tetracycline-controlled antisense bcl-2 expression on the growth and apoptosis of human neuroblastoma cell line SK-N-MC. Guan J; Chen J; Zhao H Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):135-9. PubMed ID: 12419161 [TBL] [Abstract][Full Text] [Related]
10. Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Mariani L; Beaudry C; McDonough WS; Hoelzinger DB; Kaczmarek E; Ponce F; Coons SW; Giese A; Seiler RW; Berens ME Clin Cancer Res; 2001 Aug; 7(8):2480-9. PubMed ID: 11489830 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7. Kenig S; Frangež R; Pucer A; Lah T Apoptosis; 2011 Jul; 16(7):671-82. PubMed ID: 21484410 [TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895 [TBL] [Abstract][Full Text] [Related]
13. A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas. Tasiou A; Konduri SD; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Obeyesekere M; Rao JS Int J Oncol; 2001 Sep; 19(3):591-7. PubMed ID: 11494041 [TBL] [Abstract][Full Text] [Related]
14. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth. Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266 [TBL] [Abstract][Full Text] [Related]
15. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609 [TBL] [Abstract][Full Text] [Related]
16. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Kirschke H; Eerola R; Hopsu-Havu VK; Brömme D; Vuorio E Eur J Cancer; 2000 Apr; 36(6):787-95. PubMed ID: 10762753 [TBL] [Abstract][Full Text] [Related]
17. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Rutka JT; Hubbard SL; Fukuyama K; Matsuzawa K; Dirks PB; Becker LE Cancer Res; 1994 Jun; 54(12):3267-72. PubMed ID: 8205549 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763 [TBL] [Abstract][Full Text] [Related]
19. Cathepsin L knockdown enhances curcumin-mediated inhibition of growth, migration, and invasion of glioma cells. Fei Y; Xiong Y; Zhao Y; Wang W; Han M; Wang L; Tan C; Liang Z Brain Res; 2016 Sep; 1646():580-588. PubMed ID: 27373979 [TBL] [Abstract][Full Text] [Related]
20. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas. Sivaparvathi M; Yamamoto M; Nicolson GL; Gokaslan ZL; Fuller GN; Liotta LA; Sawaya R; Rao JS Clin Exp Metastasis; 1996 Jan; 14(1):27-34. PubMed ID: 8521613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]